HealthCare Global Enterprises Limited has informed stock exchanges about executing second amendment agreements that extend the timeline for acquiring additional shares in Vizag Hospital and Cancer Research Centre Private Limited. The company filed this intimation on March 29, 2026, under SEBI listing regulations.

Acquisition Timeline Extension

The amendment modifies the Second Closing Date for acquiring a further 34% equity stake in Vizag Hospital. Under the original Share Purchase Agreement (SPA), the company was required to complete this acquisition within 18 months of the First Closing Date.

Previous Agreement History

The acquisition process began with initial agreements executed on June 28, 2024, involving both a Share Purchase Agreement with Vizag Hospital's selling shareholders and a Shareholders Agreement with continuing shareholders. These agreements were subsequently amended on October 01, 2024, before the current second amendment.

Regulatory Compliance

HealthCare Global Enterprises filed this intimation under Regulation 30(2) and (6) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company confirmed that apart from the timeline extension and necessary related amendments, no other material changes have been made to the SPA and Shareholders Agreement that would require additional disclosure under SEBI regulations.

Transaction Structure

The acquisition involves HealthCare Global Enterprises purchasing equity shares from selling shareholders while entering into arrangements with continuing shareholders of Vizag Hospital. The extended timeline provides additional flexibility for completing the second phase of this strategic acquisition in the healthcare sector.

HealthCare Global Enterprises Limited has successfully completed the allotment of equity shares under its rights issue, marking a significant milestone in the company's capital raising initiative. The Rights Issue Committee meeting held on March 27, 2026, approved the allotment of 82,94,566 equity shares to eligible shareholders and renouncees.

Rights Issue Details

The rights issue was conducted with specific terms that provided existing shareholders the opportunity to subscribe to additional shares. The issue opened on March 11, 2026, and closed on March 25, 2026, giving eligible shareholders a two-week window to participate. The record date for determining eligible shareholders was set as March 02, 2026.

Capital Structure Impact

The successful completion of the rights issue has resulted in a substantial increase in the company's paid-up equity share capital. The allotment has enhanced the company's capital base from ₹141,00,76,370 to ₹149,30,22,030, providing additional financial resources for its operations and growth initiatives.

Committee Meeting and Approval Process

The Rights Issue Committee meeting commenced at 8:10 p.m. and concluded at 10:00 p.m. on March 27, 2026. The committee worked in consultation with Kfin Technologies Limited, serving as the Registrar to the Issue, and received approval from the designated stock exchange, National Stock Exchange of India Limited, for the finalization of the basis of allotment.

Regulatory Compliance

The allotment process was conducted in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has fulfilled all regulatory requirements and disclosed the necessary information as prescribed under SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

The rights issue represents a strategic move by HealthCare Global Enterprises to strengthen its financial position and support future business objectives. The successful completion demonstrates investor confidence in the company's prospects and management's ability to execute capital raising initiatives effectively.